Express Scripts Accurately Predicts Which Patients Are Likely to Ignore Doctors' Orders
ST. LOUIS, Oct. 11 /PRNewswire/ -- Through a set of proprietary computer models, Express Scripts, Inc. (Nasdaq: ESRX ), is now able to accurately predict up to a year in advance which patients are most at risk of falling off their physician-prescribed drug therapy — and to intervene in customized ways to improve those patients' adherence.
Express Scripts announced today the completed testing of its therapy adherence predictive models. The findings from the tests demonstrate that the new predictive models are more accurate, informative, and actionable than any the industry has produced previously.
The patent-pending models apply to patient behavior in three key treatment classes: diabetes, high blood pressure, and high cholesterol. By being able to intervene in a highly targeted way, Express Scripts can help improve their overall health and reduce their need for increased medical expenditures in the future.
"The problem of non-adherence isn't new – it's easy to walk through a hospital and identify people who would not be there if they had simply taken their medications," said Steven Miller, M.D., chief medical officer at Express Scripts. "But our new predictive models allow us to do something that wasn't possible before: better identify those patients before they run into trouble, and tailor practical, patient-centric solutions that target the specific factors that put them at-risk for non-adherence."
Interventions to improve adherence include reminders, consultations with a pharmacist, lowered co-pays, transition to home delive